Randomized phase 2 study of perampanel for sporadic amyotrophic lateral sclerosis

OBJECTIVE: To evaluate the efficacy and safety of perampanel in patients with sporadic amyotrophic lateral sclerosis (SALS). METHODS: This randomized, double-blind, placebo-controlled, multicenter, phase 2 clinical study was conducted at 12 sites. Patients with probable or definite ALS as defined by...

Descripción completa

Detalles Bibliográficos
Autores principales: Aizawa, Hitoshi, Kato, Haruhisa, Oba, Koji, Kawahara, Takuya, Okubo, Yoshihiko, Saito, Tomoko, Naito, Makiko, Urushitani, Makoto, Tamaoka, Akira, Nakamagoe, Kiyotaka, Ishii, Kazuhiro, Kanda, Takashi, Katsuno, Masahisa, Atsuta, Naoki, Maeda, Yasushi, Nagai, Makiko, Nishiyama, Kazutoshi, Ishiura, Hiroyuki, Toda, Tatsushi, Kawata, Akihiro, Abe, Koji, Yabe, Ichiro, Takahashi-Iwata, Ikuko, Sasaki, Hidenao, Warita, Hitoshi, Aoki, Masashi, Sobue, Gen, Mizusawa, Hidehiro, Matsuyama, Yutaka, Haga, Tomohiro, Kwak, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782807/
https://www.ncbi.nlm.nih.gov/pubmed/34191081
http://dx.doi.org/10.1007/s00415-021-10670-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782807/
https://www.ncbi.nlm.nih.gov/pubmed/34191081
http://dx.doi.org/10.1007/s00415-021-10670-y

Ejemplares similares